acetylator phenotype can be simply determined using sulphadimidine as a test drug.
Materials and Methods
Experimental subjects and patients are detailed in Table I . Subjects who had (i) a history of asthma, hay fever, or eczema; (ii) major gastro-intestinal surgery; (iii) a history of adverse reaction to any drug; or (iv) any other serious organic disease were excluded from these experiments.
Sulphadimidine dosages were given as commercially available-scored tablets each containing 500 mg. of drug.
For the chemical analyses, ammonium sulfamate and N-1-napthyl-ethylene-diamine dihydrochloride were British Diug Houses, Reagent Grade, while other chemicals were British Drug Houses, Analytical Grade. Pure powder sulphadimidine was used to prepare standard solutions.
Procedure on Experimental Subjects and Patients. Fasting subjects swallowed their dose of sulphadimidine (Table I) as crushed tablets with a little water. Two hours after drug ingestion the subjects were allowed tea (or coffee) and toast. Thereafter normal meals were allowed. Urine was collected according to Table I , the volume measured, and a portion stored at -20°C. to await analysis. A sample of venous blood was taken as indicated in Table I , and the serum separated and stored at -20°C. to await analysis.
Series I subjects were all dosed under the supervision Received June 13, 1969. of the same research worker and all specimens were analysed by the same technicians. Series II subjects were dosed in different places under the supervision of different persons; and the specimens were analysed variously by different technicians in different laboratories. When the samples were thawed before analysis, care was taken to ensure that the sulphadimidine and acetylsulphadimidine were completely redissolved. For this purpose urine samples were placed after thawing in a boiling water bath for five minutes while thawed sera were placed in a 370 C. incubator for 1 hour.
Estimation of Sulphadimidine Concentration in Urine and Serum. Free (F) and total (T) sulphadimidine concentrations were estimated by the BrattonMarshall procedure, as given by Varley (1954) . Unknowns were processed in duplicate, and a range of standards at 2, 4, 6, 8, and 10 ,ug. sulphadimidine per ml., together with suitable blanks, were processed in duplicate simultaneously.
Calculations. The percentage of sulphadimidine acetylated is given by the formula: Table II ) 40 (see Table III Results The results are presented in Fig. 1 and 2 . A satisfactory separation of rapid and slow acetylator phenotype was obtained with both dosages. The percentage of sulphadimidine acetylated in serum seems to be a better phenotypic discriminanant than is the same parameter in urine. A figure of 37-5% serum sulphadimidine acetylated has been taken as the arbitrary dividing line between the phenotypes in Series I. Fig. 1 ) the mean was 28&05 ± SE 1 70; and for 84 slow acetylators the mean was 15-51 + SE 0-80 (Fig. 3) . Both free sulphadimidine and acetylsulphadimidine concentrations are significantly inversely correlated with urine volumes. The percentage sulphadimidine acetylated is, however, not correlated with urine volume. Discussion A small series using the same technique as Series I was reported by White and Evans (1968) , yielding a very similar result to those shown in Fig. 1 . Tiitinen (1969) 
Summary
A method of determining the acetylator phenotype in man is described. This method uses a small dose of sulphadimidine which gives minimal side-effects. One serum and one urine specimen are required; they need no special handling and the laboratory analyses are simple. There is very little overlap between the two phenotypes by this method, and it is suggested that it is appropriate, e.-. for field work, to determine gene frequencies.
